1 |
Heo J. Donguibogam. Seoul:Bubin Publishers. 2012 : 1908.
|
2 |
Lohsiriwat V. Hemorrhoids: from basic pathophysiology to clinical management. World J Gastroenterol. 2012 ; 18(17) : 2009-17.
DOI
|
3 |
Medzhitov R. Inflammation 2010 : new adventures of an old flame. Cell. 2010 ; 140 : 771-6.
DOI
|
4 |
Kaminska B. MAPK signalling pathways as molecular targets for anti-inflammatory therapy-from molecular mechanisms to therapeutic benefits. Biochim Biophys Acta. 2005 ; 1754(1-2) : 253-62.
DOI
|
5 |
Sharma JN, Al-Omran A, Parvathy SS. Role of nitric oxide in inflammatory diseases. Inflammopharmacology. 2007 ; 15(6) : 252-9.
DOI
|
6 |
Chen Z, Gibson TB, Robinson F, Silvestro L, Pearson G, Xu B, Wright A, Vanderbilt C, Cobb MH. MAP kinases. Chem Rev. 2001 ; 101 : 2449-76.
DOI
|
7 |
Coulombe P, Meloche S. Atypical mitogen-activated protein kinases : structure, regulation and functions. Biochim Biophys Acta. 2007 ; 1773 : 1376-87.
DOI
|
8 |
Tanaka T, Narazaki M, Kishimoto T. IL-6 in inflammation, immunity, and disease. Cold Spring Harb Perspect Biol. 2014 ; 6(10) :1-16.
|
9 |
Broom OJ, Widjaya B, Troelsen J, Olsen J, Nielsen OH. Mitogen activated protein kinases : a role in inflammatory bowel disease. Clin Exp Immunol. 2009 ; 158(3) : 272-80.
DOI
|
10 |
Kaminska B. MAPK signalling pathways as molecular targets for anti-inflammatory therapy-from molecular mechanisms to therapeutic benefits. Biochim Biophys Acta. 2005 ; 1754(1-2) : 253-62.
DOI
|